Discontinuation report AVELOX I.V.

Last updated on 2020-07-14 History
Report ID 73405
Drug Identification Number 02246414
Brand name AVELOX I.V.
Common or Proper name Moxifloxacin Injection
Company Name BAYER INC
Market Status MARKETED
Active Ingredient(s) MOXIFLOXACIN
Strength(s) 400MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 250 mL
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-07-03
Actual discontinuation date 2020-06-29
Remaining supply date 2020-07-03
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-01-23 English Compare
v2 2019-01-23 French Compare
v3 2020-01-09 English Compare
v4 2020-01-09 French Compare
v5 2020-01-27 English Compare
v6 2020-01-27 French Compare
v7 2020-03-04 English Compare
v8 2020-03-04 French Compare
v9 2020-03-30 English Compare
v10 2020-03-30 French Compare
v11 2020-06-30 English Compare
v12 2020-06-30 English Compare
v13 2020-06-30 French Compare
v14 2020-07-14 English Compare
v15 2020-07-14 French Compare